EntryPoint Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

EntryPoint Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,433	Closed	-$56.8K	–	1956
2024 Q1	$56.8K	Buy	1,433 +1,326	+1,239%	+$39.1K	0.05%	695
2023 Q4	$2.04K	Buy	+107	New	+$1.49K	﹤0.01%	1275

EntryPoint Capital's ALPN Position: Q2 2024 in Review

EntryPoint Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,433 shares — an estimated $56.8K sold.

EntryPoint Capital first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $56.8K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

EntryPoint Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
EntryPoint Capital sold 1,433 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $56.8K.
EntryPoint Capital first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
EntryPoint Capital's Alpine Immune Sciences Inc position peaked at $56.8K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.